Home /
Immunotherapy Treatment Results – Memorial Hermann Hospital
|
|
Description: |
Patients: This Phase I study involved 29 patients with a variety of different cancers. One patient had mesothelioma.
Treatment: The treatment consisted of injections of recombinant human interleukin-12 (a protein). Toxicity: Toxicities for all patients included grade 4 lymphopenia, and grade 3 or less nausea, vomiting, fatigue, fever, infection, and abdominal pain. Results: Of 29 patients, two experienced complete response – the patient with mesothelioma is without progression at two years. Correspondence: Ralph S. Freedman, MD |